Peptide PilotPeptide Pilot

mg ↔ units

GHRP-6 mg to units converter

Set your GHRP-6 vial concentration once, then flip in either direction between milligrams and U-100 syringe units.

Download Peptide PilotiPhone · Free to download

mg

0.100

units

4.00

mL

0.040

Concentration: 2.50 mg/mL (assumes a U-100 insulin syringe).

GHRP-6 is a short-acting injectable peptide people use to trigger pulses of their own growth hormone, often when increased appetite is also a goal. Like GHRP-2, it mimics ghrelin at the GH-secretagogue receptor, but it produces a noticeably stronger hunger response. Studies confirm clear post-injection GH peaks alongside meaningful appetite stimulation. This page covers reconstitution math and per-injection logging cadence.

How the GHRP-6 mg ↔ units converter works

This converter is a two-way bridge between dose mass (mg or mcg) and the unit count you actually draw on an insulin syringe. Once you set the GHRP-6 concentration of your current vial, you can type any mg value and read the units back, or type any unit count and read the mg back. It is the same math as the dose calculator, but bidirectional, which matters when you are checking a dose someone else recorded in units against a protocol written in mg.

The formula in both directions: mg = mL × concentration mg/mL, and units = mL × 100 on a U-100 syringe. With a 2.5 mg/mL GHRP-6 solution, 0.1 mg comes out to 4 units, and 4 units comes out to 0.1 mg. The converter handles the unit flip automatically so you never multiply or divide in your head while holding a syringe.

Concentration is the input that changes the answer most. A 5 mg vial diluted with 1 mL is twice as concentrated as the same vial diluted with 2 mL, which means the same dose draws half as many units. That is the single biggest source of converter confusion: a remembered unit count from an old vial does not transfer to a new vial reconstituted with different water volume.

Use the converter whenever a protocol or research note is written in one unit and your syringe is labeled in the other. It is also useful for sanity-checking that a planned titration step lands at a unit count you can read accurately on the syringe — under five units gets hard to read, over fifty starts crowding into the back third of a 1 mL syringe.

Why this matters for GHRP-6

GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is the foundational molecule in the growth hormone releasing peptide class, first synthesized and studied in the 1980s. Its development established that small synthetic peptides could elicit significant growth hormone pulses via a mechanism distinct from GHRH. The defining characteristic of GHRP-6, which separates it from its successors like GHRP-2 and ipamorelin, is a powerful appetite-stimulating effect that mirrors the action of the endogenous hormone ghrelin. This orexigenic property makes it a unique subject of study, particularly in research contexts monitoring caloric intake, appetite signaling, or body weight in underweight subjects.

Compared to later-generation GHRPs, GHRP-6 demonstrates a less selective activity profile, causing more pronounced transient elevations in cortisol and prolactin. This specific asymmetry was the primary impetus for the development of more refined molecules with greater receptor selectivity. For personal tracking and data analysis, this profile suggests that a log should not only document dosing and GH-related markers but also systematically record hunger levels, sleep quality, and other physiological variables. The analyzable unit of data is therefore not the response to a single administration but the aggregate trend observed over a multi-week documentation period.

GHRP-6 mechanism in plain English

GHRP-6 functions as a synthetic agonist for the growth hormone secretagogue receptor, type 1a (GHS-R1a). This is the identical receptor targeted by the natural hormone ghrelin, which is involved in both GH regulation and hunger signaling. The molecule's binding action at this receptor in the hypothalamus and pituitary gland directly initiates the release of a growth hormone pulse from somatotroph cells. Its less-refined structure allows it to mimic ghrelin's broad physiological actions more closely than subsequent peptides, accounting for its robust effect on appetite alongside its somatotropic function. This dual activity is a hallmark of GHRP-6's documented mechanism of action, operating independently of the GHRH receptor pathway.

Tracking GHRP-6 unit counts

For GHRP-6, the most distinctive and valuable data point to track is the subjective intensity of hunger following each administration. This can be recorded on a simple 1-to-10 numerical scale, where a score of 1 indicates no discernible change and 10 represents a powerful, urgent feeling of hunger. Systematically logging this rating alongside the dose amount, time, and a corresponding sleep quality score provides a robust dataset. Over a 4- to 6-week period, the trends in these variables, rather than any single day's data, offer the most meaningful material for analysis of the molecule's specific effects.

Common GHRP-6 conversion mistakes

  • Failing to document the potent hunger response on a consistent scale, mistaking a primary mechanistic effect for an incidental side effect.
  • Interpreting the transient increases in cortisol and prolactin as an unexpected deviation, rather than a well-documented characteristic of this first-generation molecule.
  • Analyzing data on a day-to-day basis instead of observing the aggregate trends in appetite and sleep quality scores over a multi-week timeline.
  • Neglecting to record the administration time relative to meals, which is a crucial variable for contextualizing the peptide's orexigenic impact.
  • Structuring a personal tracking log based on a template for a highly selective peptide like ipamorelin, thus omitting fields for hunger and other variables unique to GHRP-6.

Frequently asked questions about GHRP-6 mg ↔ units

How does tracking for GHRP-6 differ from tracking for ipamorelin or GHRP-2?
The primary distinction is the emphasis on appetite monitoring. A log for ipamorelin would focus almost exclusively on GH-related metrics, whereas a log for GHRP-6 should feature a hunger rating (e.g., on a 1–10 scale) as a primary data field. Because GHRP-6 binds to the ghrelin receptor in a manner that strongly stimulates appetite, this orexigenic effect is a direct part of its mechanism to be observed, not a secondary consideration.
What do historical research studies indicate about cortisol and prolactin with GHRP-6?
Scientific literature dating back to the 1980s consistently shows that GHRP-6 administration leads to measurable, dose-dependent increases in plasma cortisol and prolactin. This effect is significantly more pronounced than that observed with its successors, GHRP-2 and ipamorelin. In fact, the desire to reduce these off-target hormonal effects was a major driver behind the development of those later-generation peptides.
If a 5 mg vial is prepared with 2 mL of diluent, how many units is a 100 mcg dose?
With 5 mg (or 5,000 mcg) of peptide dissolved in 2 mL of diluent, the solution's concentration becomes 2,500 mcg/mL. A U-100 syringe contains 100 units per mL, meaning each single unit delivers 25 mcg of peptide (2,500 mcg ÷ 100 units). To calculate the volume for a 100 mcg dose, one would divide the target dose by the per-unit concentration (100 mcg ÷ 25 mcg/unit), which results in a required volume of 4 units.
Why is it important to document the timing of administration relative to food intake?
Documenting administration timing against meal consumption is critical because GHRP-6 is a potent appetite stimulant. An administration on a fasted stomach may elicit a very different hunger response compared to one given shortly after a meal. Consistently recording this variable allows a researcher to better isolate and observe the peptide's direct orexigenic action across a study period.
What is the significance of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 being the 'original' GHRP?
Its discovery demonstrated the principle that small, synthetic peptides could potently stimulate GH release through a novel receptor, now known as the GHS-R1a. As the first of its kind, its well-documented activity profile, including the strong hunger effect and cortisol/prolactin elevation, served as the scientific baseline. This baseline provided the rationale for subsequent molecular engineering to create more selective agonists like ipamorelin.
Is it more useful to log data daily or to study patterns across weeks with GHRP-6?
Daily entries are necessary to capture raw data, such as dose, hunger score, and sleep rating. However, the most informative insights are derived from studying the trends and averages of this data over multiple weeks. A single day's hunger can be influenced by numerous external factors, but a pattern that emerges across a 4- to 6-week period of consistent documentation is more likely to reflect the molecule's specific influence.

Related on Peptide Pilot

Save your GHRP-6 vial in the app

Download on the App Store
Get the App